Aramark

NYSE:ARMK

Specialty Business Services

Industrials
$56.85 -1.62%

-$0.88 today

Market cap
$14.99B
Beta
1.19
P/E (TTM)
39.4
EPS (TTM)
$1.36
Dividend yield
0.87%
52W Low $35.07High $54.93

Volume 3.37M

Average 2.79M

ARMK Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

AramarkNYSE: ARMK

Research & Development · Q4 FY2026 · quarter ended Oct 2026

Research & development remains negative

Q4 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterOct 2026
$0— QoQ
Last fiscal yearOct 2026
$0— YoY
LTMOct 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
0 USD
Year-over-year change
—

Research & Development vs competitors

How ARMK compares with its peers on the latest reported figures

  • ARMK's LTM Oct 2026 research & development of $0 is the highest of the 3 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for ARMK, versus a peer median of 0.0%.
ARMK Competitors Peer median
Research & Development for ARMK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ARMKAramarkLTM Oct 2026$0 ——0.0%
CTASCintas CorporationLTM Aug 2026$0 -100.0%—0.0%
ABMABM Industries IncorporatedLTM Jul 2026$0 ——0.0%
Peer median (excluding ARMK) $0-100.0%—0.0%

Competitors are the stored peer set for ARMK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Oct 2025
FY2026
Oct 2026
Revenue13.69B16.08B17.4B18.51B20.09B
Cost of Revenue12.62B14.77B15.98B17.44B18.32B
Gross Profit1.07B1.31B1.43B1.07B1.77B
Gross Margin7.8%8.1%8.2%5.8%8.8%
Research & Development00000
Selling, General & Admin258.36M273.66M283.63M278.44M0
Operating Expenses656.33M683.52M719.17M278.44M850.84M
Depreciation & Amortization532.33M409.86M435.55M476.35M533.58M
EBITDA964.4M1.44B1.19B1.25B1.45B
EBITDA Margin7.0%9.0%6.8%6.7%7.2%
Operating Income415.39M625.03M706.51M791.85M917.27M
Operating Margin3.0%3.9%4.1%4.3%4.6%
Interest Income16.68M29.81M22.48M22.45M0
Interest Expense384.86M467.29M389.19M364.38M321.39M
Other Income / Expenses(368.18M)(61.5M)(341.65M)(361.39M)(321.39M)
Income Before Tax47.21M563.52M364.87M430.46M595.88M
Pre-Tax Margin0.3%3.5%2.1%2.3%3.0%
Income Tax Expense8.43M116.43M102.97M103.59M159.49M
Net Income194.48M674.11M262.52M326.39M433.71M
Net Margin1.4%4.2%1.5%1.8%2.2%
EPS (Basic)0.762.591.001.241.65
EPS (Diluted)0.752.570.991.221.62
Weighted Avg Shares257.31M260.59M263.05M263.86M263.49M
Weighted Avg Shares (Diluted)259.07M262.59M266.2M267.35M268.03M

Aramark

NYSE:ARMK

Intrinsic Alpha fair value

Locked

Current Price

$56.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.